Citius Oncology, Inc.

Healthcare

NASDAQ:CTOR · NASDAQ Global Market

Market Cap $64.39M Beta 3.42 P/E (TTM) -1.6

$0.66 -4.12%

-$0.03 today

52W Low $0.49High $6.19

Vol 0.04M · Avg 0.14M

EPS (TTM)-$0.42

Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-54.83%

Period High

$5.29

Period Low

$0.49

Latest

$0.66

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Forte Biosciences, Inc.

NASDAQ:FBRX

$243.83M

Fate Therapeutics, Inc.

NASDAQ:FATE

$240.11M

Spero Therapeutics, Inc.

NASDAQ:SPRO

$165.02M

Vor Biopharma Inc.

NASDAQ:VOR

$98.42M

Owlet, Inc.

NYSE:OWLT

$84.14M

Scilex Holding Company

NASDAQ:SCLX

$72.18M

LENSAR, Inc.

NASDAQ:LNSR

$70.45M

Seres Therapeutics, Inc.

NASDAQ:MCRB

$55.20M

Actuate Therapeutics Inc

ACTU

$48.33M

Applied Therapeutics, Inc.

APLT

$14.86M

What is the latest CTOR filing?

The latest filing shown is 424B3 dated Jun 1, 2026.

How many recent filings does CTOR have?

Intrinsic Alpha currently shows 20 recent filings for CTOR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.